PatelNJDeshmukhAPantS, et al.
Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010. Circulation2014;
129: 2371–2379.
2.
WolowaczSESamuelMBrennanVK, et al.
The cost of illness of atrial fibrillation: A systematic review of the recent literature.Europace2011;
13: 1375–1385.
3.
FribergLRosenqvistM.Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: Report from the Stockholm Cohort Study of Atrial Fibrillation.Europace2011;
13: 626–633.
4.
InoharaTShraderPPieperK, et al.
Association of atrial fibrillation clinical phenotypes with treatment patterns and outcomes: A multicenter registry study. JAMA Cardiol2018;
3: 54–63.
5.
DeVoreADHellkampASBeckerRC, et al.
Hospitalizations in patients with atrial fibrillation: An analysis from ROCKET AF.Europace2016;
18: 1135–1142.
6.
SteinbergBAKimSFonarowGC, et al.
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J2014;
167: 735–742.e732.
7.
KwonOKKimSHKangSH, et al.
Association of short- and long-term exposure to air pollution with atrial fibrillation. Eur J Prev Cardiol2019;
26: 1208–1216.
8.
MeyrePAeschbacherSBlumS, et al.
The Admit-AF risk score: A clinical risk score for predicting hospital admissions in patients with atrial fibrillation. Eur J Prev Cardiol2020. Epub ahead of print: 10.1177/2047487320915350.
9.
ConenDRodondiNMuellerA, et al.
Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): Structural brain damage and cognitive decline among patients with atrial fibrillation. Swiss Med Wkly2017;
147: w14467.
10.
Ruperti RepiladoFJDoerigLBlumS, et al.
Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation. Swiss Med Wkly2018;
148: w14652.
11.
GuoJNayakHMBesserSA, et al.
Impact of atrial fibrillation ablation on recurrent hospitalization: A nationwide cohort study. JACC Clin Electrophysiol2019;
5: 330–339.
12.
LoringZShraderPAllenLA, et al.
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J2020;
219: 21–30.
13.
Przewlocka-KosmalaMJasic-SzpakERojekA, et al.
Association of central blood pressure with left atrial structural and functional abnormalities in hypertensive patients: Implications for atrial fibrillation prevention. Eur J Prev Cardiol2019;
26: 1018–1027.